Full-Time

Drug Discovery Data Scientist

Confirmed live in the last 24 hours

Schrödinger

Schrödinger

501-1,000 employees

Computational platform for biopharmaceutical research

Government & Public Sector
Enterprise Software
Biotechnology

Compensation Overview

$65k - $85kAnnually

Junior, Mid

Portland, OR, USA

Category
Data Management
Data Analysis
Data Engineering
Data & Analytics
Required Skills
Power BI
Python
R
Git
Tableau
Pandas
NumPy
Looker
Data Analysis
Google Cloud Platform
Requirements
  • A Bachelor’s degree in a STEM field
  • Robust proficiency in data visualization tools (e.g. Tableau, Power BI, Looker etc.)
  • Experience with any of the following is a plus: Data management and analysis libraries in Python and/or R (e.g., Pandas, Numpy, Scipy), Cloud compute and storage platforms, especially GCP, Version control (e.g., Git), Data Engineering platforms and pipelining tools such as Apache Airflow, Cheminformatics and/or bioinformatics tools (e.g. RDKit, FastQC), Online sources of scientific information (especially NCBI PubMed, RCSB PDB, UniProtKB, EMBL-EBI ChEMBL, SciFinder, Reaxys), Stereochemistry
Responsibilities
  • Research, curate, and prepare computational chemistry and genomics data sets, as well as compile, clean, and summarize results and metadata
  • Find, prepare, and maintain data, which could include: processing proprietary data and information according to guidelines, managing data on Google Cloud Platform, collaborating with key internal or external advisors to determine what data they need, collecting key data by using a wide variety of public and paid scientific sources, documenting collection and data transformation work
  • Support data-related technical issues

Schrödinger provides a computational platform that aids in the research efforts of biopharmaceutical companies, academic institutions, and government laboratories around the world. The platform offers advanced computational tools that help in drug discovery and research across various therapeutic areas. Schrödinger's products work by utilizing sophisticated algorithms and simulations to predict molecular behavior, which assists researchers in identifying potential drug candidates more efficiently. What sets Schrödinger apart from its competitors is its extensive global reach, serving clients in over 70 countries, and its dual focus on both software licensing and collaborative drug discovery programs. The company's goal is to advance scientific research and talent, ultimately enhancing the drug discovery process to bring new therapies to market.

Company Stage

IPO

Total Funding

$362.7M

Headquarters

New York City, New York

Founded

1990

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • $19.5M Gates Foundation grant boosts platform for neglected diseases, expanding market reach.
  • Predictive toxicology tools initiative could lead to safer, efficient drug development.
  • SGR-1505 discovery showcases ability to reduce drug discovery timelines significantly.

What critics are saying

  • Recursion and Exscientia merger creates strong AI-driven drug discovery competitor.
  • Avicenna's independent expansion could lead to competitive tensions with Schrödinger.
  • High R&D costs may strain resources despite Gates Foundation's $10M grant.

What makes Schrödinger unique

  • Schrödinger's platform supports diverse clients, including biopharma, academia, and government labs.
  • The company excels in rapid drug discovery, exemplified by SGR-1505's swift development.
  • Schrödinger's collaboration with Avicenna enhances medicinal chemistry through machine learning.

Help us improve and share your feedback! Did you find this helpful?